Promotions & Moves

Lonza CEO Steps Down

Albert Baehny, chairman, will take on the responsibility on an interim basis.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Lonza’s chief executive officer, Marc Funk, will leave the Company for personal reasons. Albert Baehny, chairman, will take on the additional responsibility of chief executive officer on an interim basis until a permanent successor is named. Marc will remain with the company until January 2020 to ensure a smooth transition. Also, board member Christoph Maeder has been appointed Lead Independent Director by the Board. Christoph Maeder, Lead Independent Director said, “Albert has agreed to lead t...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters